Medical Marijuana, Inc. Subsidiary Kannaway® Expands Into Russia, Kazakhstan and Kyrgyzstan

SAN DIEGO, Jan. 28, 2020 /PRNewswire/ — Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary Kannaway® is now available in Russia, Kazakhstan and Kyrgyzstan. Kannaway® was the first direct selling company to offer hemp-derived cannabidiol (CBD) products in both the U.S. and Europe. The Company currently ships its products to over 30 countries in Europe and throughout the United States. In June 2019, Kannaway® announced its expansion into the Asian market and this expansion into Russia, Kazakhstan and Kyrgyzstan is part of the Company’s aggressive international expansion plans. “Kannaway has pioneered direct selling hemp-derived CBD in the U.S.…

Excerpt only …
READ MORE BELOW
Source : CANNANNEW REPORT
Link to original : Medical Marijuana, Inc. Subsidiary Kannaway® Expands Into Russia, Kazakhstan and Kyrgyzstan
reposted by Cannabis News World